Dividend payable to shareholders who have not yet updated their KYC details is withheld and shall be released upon compliance with the KYC norms.

Haleos October 31, 2026 BSE Limited, National stock Exchange of India Limited, Listing Department, P J Towers, Listing Department, "Exchange Plaza", Dalal street, Bandra-Kurla Complex, Bandra (El, Mumbai - 400 001. Mumbai -400 051. Scri Code:540679 Trading Symbol: HALEOSLABS SUB: TEMPORARY WITHHOLDINC OF DIVIDEND PENDINC KYC UPDATION_ Ref: SEBI circular no_ SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31,2024_ Dear Sir/Madam, We would like to inform that we have sent individual letters to those shareholders of the Company on October 31,2026 (todayl, who have not updated their KYC details (Bank mandatesl as required in the SEBI Circular dated November 3, 2021 against the respective folios, intimating them about the declaration of dividend by the shareholders at the 20th Annual General Meeting and that the dividend ayable a ainst their holdin s is temporaril withheld and shall be released onl upon com I ing with the requirements of u dation of KYC as provided in the SEBI Circular(sl. Kindly take the same on record and suitably disseminate it to all concerned. For Haleos Labs Limited Haleos Labs Limited (Formerly SMS Lifesciences India limited) Registered & Corporate Offlca: Plot No. 19-111, Road No. 71, Opp. Bharatiya Vldya Bhavan Public School, Jubilee Hills, Hyderabad -500 096, Telangana, India. Tel: +91-40-8628 88881 CIN -L74930TG200BPLC050223I info@haleoslabs.com I www.haleoslabs.com Haleos Labs Limited (Formerly known as SMS Lifesciences India Limited) CIN: L74930TG2006PLC050223 Office Address: Plot No.19-III, Road No.71, Jubilee Hills, Opp. Bharatiya Vidya Bhavan Public School, Hyderabad - 500096 Email ID: cs@haleoslabs.com Website: www.haleoslabs.com Ref: SLS/DIVIDEND/REJ. 2025-2026/70001 Date: 28-10-2026 PRASANNA KUMAR TUMMALA HNO21KAMALAPURI COLONY PHASE - 3 INDIRA NAGARHYDERABAD Sub: Payment of Dividend (FY 2025-26) on hold due to Non-Updation of KYC / Rejection by Banker for Incorrect Bank Account Details-Reg. Ref: DPID-Client ID/Folio No. : 50039 Dear Shareholder, In continuation to our earlier correspondence dated May 25, 2026 and pursuant to the SEBI Master Circular for Registrar and Share Transfer Agents dated June 23, 2025, read with Circular No. SEBI//HO/MIRSD/POD-1/P/CIR/2024/81 dated June 10, 2024, we wish to inform you that the shareholders of Haleos labs Limited (previously known as SMS Lifesciences India Limited) (the Company) at their 20th Annual General Meeting [AGM] held on 30th September, 2026, had approved dividend for the financial year 2025-26 @ 15% i.e. ₹1.50/- per equity share of ₹10/ - each. Dividend details: Folio No/DP ID & Client ID 50039 No. of Shares 3 Warrant No 406589 Gross Dividend (Rs.) 4.5 TDS Amount (Rs.) 1 Total Tax Deducted (Rs.) 1 Net Dividend Payable (Rs.) 3.5 Reason for Rejection received from Banker/Kept Non Availability of KYC Details on Hold due to The dividend payable on your shares has been withheld due to one or more of the following reasons: 1) Non-updation of KYC details (e.g., PAN, Address, Email ID, Mobile No., or Bank Mandate); and/or 2) Rejection of dividend payment by your banker due to incorrect / incomplete Bank Account Number, IFSC, or MICR Code. We request you to kindly update your KYC details and/or submit correct bank account particulars at the earliest to enable us to process the dividend payment. If you are a Physical Shareholder, the documents/details, as per the table below are to be submitted to our Registrar & Share Transfer Agent (RTA) at Aarthi Consultants Private Limited, # 1-2-285, Domalguda, Hyderabad-500029, Telangana, India, Email: info@aarthiconsultants.com, Phone: 040-27638111, 27642217: S. No. Purpose Form No. 1 Request for registering PAN, KYC details or changes/ updation thereof Form ISR-1 2. Confirmation of Signature of securities holder by the Banker Form ISR-2 3. Registration of Nomination (Nomination Form) * Form SH-13 4. Declaration Form for Opting-out of Nomination* Form ISR -3 5. Cancellation or Variation of Nomination Form SH-14 6. Cancelled Cheque with Name of the Shareholder, Bank A/C No, MICR and IFSC code Original *In case you are opting out for giving nomination, submit Form ISR-3 and Form SH-13 need not be submitted. If you are Electronic Shareholder, you are requested to update the Bank Account details with Depository Participant (DP) and share us updated Client Master Copy along with self-attested PAN, Aadhar and Original Cancelled Cheque leaf with Name of the Shareholder, Bank Account Number, IFSC and MICR code for Dividend Processing electronically. Alternatively, you may download the requisite forms from our RTA Website: https://www.aarthiconsultants.com/investors/login.php and Company’s website at: https://haleoslabs.com/wp-content/uploads/2026/01/KYC-updation-forms.pdf Upon receipt and verification of your updated details, the withheld dividend will be released to your registered bank account. Thank you for your cooperation. Yours faithfully, For Haleos Labs Limited (Formerly known as “SMS Lifesciences India Limited”) Sd/- Trupti Ranjan Mohanty Company Secretary